Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 951706, 8 pages
http://dx.doi.org/10.1155/2015/951706
Research Article

Mutations Found in embCAB, embR, and ubiA Genes of Ethambutol-Sensitive and -Resistant Mycobacterium tuberculosis Clinical Isolates from China

1Molecular Laboratory, Beijing Chest Hospital, Capital Medical University, 97 Machang Road, Tongzhou District, Beijing 101149, China
2Beijing Key Laboratory for Drug Resistance Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, 97 Machang Road, Tongzhou District, Beijing 101149, China
3National Tuberculosis Clinical Laboratory, Beijing Chest Hospital, Capital Medical University, 97 Machang Road, Tongzhou District, Beijing 101149, China

Received 8 June 2015; Revised 7 August 2015; Accepted 19 August 2015

Academic Editor: Sherry L. Mowbray

Copyright © 2015 Yuhui Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Thoracic Society, CDC, and Infectious Diseases Society of America, “Treatment of tuberculosis,” Morbidity and Mortality Weekly Report—Recommendations and Reports, vol. 52, no. RR11, pp. 1–77, 2003. View at Google Scholar
  2. A. Y. Coban, A. Deveci, A. T. Sunter, and A. Martin, “Nitrate reductase assay for rapid detection of isoniazid, rifampin, ethambutol, and streptomycin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis,” Journal of Clinical Microbiology, vol. 52, no. 1, pp. 15–19, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Feng, S. Liu, Q. Wang et al., “Rapid diagnosis of drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol using genotype MTBDRsl Assay: a meta-analysis,” PLoS ONE, vol. 8, no. 2, Article ID e55292, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Safi, S. Lingaraju, A. Amin et al., “Evolution of high-level ethambutol-resistant tuberculosis through interacting mutations in decaprenylphosphoryl-β-D-Arabinose biosynthetic and utilization pathway genes,” Nature Genetics, vol. 45, no. 10, pp. 1190–1197, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Radmacher, K. C. Stansen, G. S. Besra et al., “Ethambutol, a cell wall inhibitor of Mycobacterium tuberculosis, elicits L-glutamate efflux of Corynebacterium glutamicum,” Microbiology, vol. 151, no. 5, pp. 1359–1368, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. F. Yen, M. S. Chung, H. Y. Hu et al., “Association of pulmonary tuberculosis and ethambutol with incident depressive disorder: a nationwide, population-based cohort study,” Journal of Clinical Psychiatry, vol. 76, no. 4, pp. 505–511, 2015. View at Publisher · View at Google Scholar
  7. S. Sreevatsan, K. E. Stockbauer, X. Pan et al., “Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations,” Antimicrobial Agents and Chemotherapy, vol. 41, no. 8, pp. 1677–1681, 1997. View at Google Scholar · View at Scopus
  8. Y. Xu, Z. Zhang, and Z. Sun, “Drug resistance to Mycobacterium tuberculosis: from the traditional Chinese view to modern systems biology,” Critical Reviews in Microbiology, vol. 41, no. 3, pp. 399–410, 2015. View at Publisher · View at Google Scholar
  9. C. Plinke, H. S. Cox, N. Zarkua et al., “embCAB sequence variation among ethambutol-resistant Mycobacterium tuberculosis isolates without embB306 mutation,” Journal of Antimicrobial Chemotherapy, vol. 65, no. 7, Article ID dkq120, pp. 1359–1367, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Safi, R. D. Fleischmann, S. N. Peterson, M. B. Jones, B. Jarrahi, and D. Alland, “Allelic exchange and mutant selection demonstrate that common clinical embCAB gene mutations only modestly increase resistance to ethambutol in Mycobacterium tuberculosis,” Antimicrobial Agents and Chemotherapy, vol. 54, no. 1, pp. 103–108, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. A. E. Belanger, G. S. Besra, M. E. Ford et al., “The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 21, pp. 11919–11924, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Huang, M. S. Scherman, W. D'Haeze et al., “Identification and active expression of the Mycobacterium tuberculosis gene encoding 5-phospho-α-D-ribose-1-diphosphate: decaprenyl-phosphate 5-phosphoribosyltransferase, the first enzyme committed to decaprenylphosphoryl-D-arabinose synthesis,” The Journal of Biological Chemistry, vol. 280, no. 26, pp. 24539–24543, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. Z. Sun, J. Zhang, H. Song et al., “Concomitant increases in spectrum and level of drug resistance in Mycobacterium tuberculosis isolates,” The International Journal of Tuberculosis and Lung Disease, vol. 14, no. 11, pp. 1436–1441, 2010. View at Google Scholar · View at Scopus
  14. H. Masur, “Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus,” The New England Journal of Medicine, vol. 329, no. 12, pp. 898–904, 1993. View at Publisher · View at Google Scholar
  15. R. Moure, M. Español, G. Tudó et al., “Characterization of the embB gene in Mycobacterium tuberculosis isolates from Barcelona and rapid detection of main mutations related to ethambutol resistance using a low-density DNA array-authors' response,” Journal of Antimicrobial Chemotherapy, vol. 69, no. 8, pp. 2299–2300, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. Z. Bakuła, A. Napiórkowska, J. Bielecki, E. Augustynowicz-Kopeć, Z. Zwolska, and T. Jagielski, “Mutations in the embB gene and their association with ethambutol resistance in multidrug-resistant mycobacterium tuberculosis clinical isolates from Poland,” BioMed Research International, vol. 2013, Article ID 167954, 5 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Shi, L. Li, Y. Zhao et al., “Characteristics of embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates in Henan, China,” Journal of Antimicrobial Chemotherapy, vol. 66, no. 10, Article ID dkr284, pp. 2240–2247, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. J.-H. Yoon, J.-S. Nam, K.-J. Kim et al., “Molecular characterization of drug-resistant and -susceptible Mycobacterium tuberculosis isolated from patients with tuberculosis in Korea,” Diagnostic Microbiology and Infectious Disease, vol. 72, no. 1, pp. 52–61, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Perdigão, R. Macedo, A. Ribeiro, L. Brum, and I. Portugal, “Genetic characterisation of the ethambutol resistance-determining region in Mycobacterium tuberculosis: prevalence and significance of embB306 mutations,” International Journal of Antimicrobial Agents, vol. 33, no. 4, pp. 334–338, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Brossier, N. Veziris, A. Aubry, V. Jarlier, and W. Sougakoff, “Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates,” Journal of Clinical Microbiology, vol. 48, no. 5, pp. 1683–1689, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Srivastava, A. Ayyagari, T. N. Dhole, K. K. Nyati, and S. K. Dwivedi, “emb nucleotide polymorphisms and the role of embB306 mutations in Mycobacterium tuberculosis resistance to ethambutol,” International Journal of Medical Microbiology, vol. 299, no. 4, pp. 269–280, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Plinke, H. S. Cox, S. Kalon, D. Doshetov, S. Rüsch-Gerdes, and S. Niemann, “Tuberculosis ethambutol resistance: concordance between phenotypic and genotypic test results,” Tuberculosis, vol. 89, no. 6, pp. 448–452, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. S. V. Ramaswamy, A. G. Amin, S. Göksel et al., “Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis,” Antimicrobial Agents and Chemotherapy, vol. 44, no. 2, pp. 326–336, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. W.-L. Huang, T.-L. Chi, M.-H. Wu, and R. Jou, “Performance assessment of the GenoType MTBDRsl test and DNA sequencing for detection of second-line and ethambutol drug resistance among patients infected with multidrug-resistant Mycobacterium tuberculosis,” Journal of Clinical Microbiology, vol. 49, no. 7, pp. 2502–2508, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. L. I. Zhao, Q. Sun, H. C. Liu et al., “Analysis of embCAB mutations associated with ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis isolates from China,” Antimicrobial Agents and Chemotherapy, vol. 59, no. 4, pp. 2045–2050, 2015. View at Publisher · View at Google Scholar
  26. A. M. Starks, A. Gumusboga, B. B. Plikaytis, T. M. Shinnick, and J. E. Posey, “Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 3, pp. 1061–1066, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. G. P. S. Jadaun, R. Das, P. Upadhyay, D. S. Chauhan, V. D. Sharma, and V. M. Katoch, “Role of embCAB gene mutations in ethambutol resistance in Mycobacterium tuberculosis isolates from India,” International Journal of Antimicrobial Agents, vol. 33, no. 5, pp. 483–486, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Goude, A. G. Amin, D. Chatterjee, and T. Parish, “The arabinosyltransferase EmbC is inhibited by ethambutol in Mycobacterium tuberculosis,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 10, pp. 4138–4146, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. C. U. Köser, D. K. Summers, and J. A. C. Archer, “Thr270Ile in embC (Rv3793) is not a marker for ethambutol resistance in the Mycobacterium tuberculosis complex,” Antimicrobial Agents and Chemotherapy, vol. 55, no. 4, article 1825, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. L. He, X. Wang, P. Cui et al., “ubiA (Rv3806c) encoding DPPR synthase involved in cell wall synthesis is associated with ethambutol resistance in Mycobacterium tuberculosis,” Tuberculosis, vol. 95, no. 2, pp. 149–154, 2015. View at Publisher · View at Google Scholar
  31. H. Safi, B. Sayers, M. H. Hazbon, and D. Alland, “Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin,” Antimicrobial Agents and Chemotherapy, vol. 52, no. 6, pp. 2027–2034, 2008. View at Publisher · View at Google Scholar
  32. C. Plinke, K. Walter, S. Aly, S. Ehlers, and S. Niemann, “Mycobacterium tuberculosis embB codon 306 mutations confer moderately increased resistance to ethambutol in vitro and in vivo,” Antimicrobial Agents and Chemotherapy, vol. 55, no. 6, pp. 2891–2896, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Ängeby, P. Juréen, G. Kahlmeter, S. E. Hoffner, and T. Schönd, “Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis,” Bulletin of the World Health Organization, vol. 90, no. 9, pp. 693–698, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. X. Zhang, L. Liu, Y. Zhang, G. Dai, H. Huang, and Q. Jina, “Genetic determinants involved in p-aminosalicylic acid resistance in clinical isolates from tuberculosis patients in northern China from 2006 to 2012,” Antimicrobial Agents and Chemotherapy, vol. 59, no. 2, pp. 1320–1324, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. Z. Zhang, Y. Wang, Y. Pang, and K. M. Kam, “Ethambutol resistance as determined by broth dilution method correlates better than sequencing results with embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates,” Journal of Clinical Microbiology, vol. 52, no. 2, pp. 638–641, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. Z. Mei, Z. Sun, D. Bai et al., “Discrepancies in drug susceptibility test for tuberculosis patients resulted from the mixed infection and the testing system,” BioMed Research International, vol. 2015, Article ID 651980, 7 pages, 2015. View at Publisher · View at Google Scholar
  37. M. Sareen and G. K. Khuller, “Cell wall and membrane changes associated with ethambutol resistance in Mycobacterium tuberculosis H37Ra,” Antimicrobial Agents and Chemotherapy, vol. 34, no. 9, pp. 1773–1776, 1990. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Ahmad, E. Mokaddas, and A.-A. Jaber, “Rapid detection of ethambutol-resistant Mycobacterium tuberculosis strains by PCR-RFLP targeting embB codons 306 and 497 and iniA codon 501 mutations,” Molecular and Cellular Probes, vol. 18, no. 5, pp. 299–306, 2004. View at Publisher · View at Google Scholar · View at Scopus